Stock Information
10X Genomics Inc (TXG)
Ticker Symbol: TXG
Exchange: NASDAQ
Sector: Life Sciences Tools & Services
Market Cap: $0.00 mil
Piotroski score: 5
PE Ratio: N/A
EPS (TTM): -0.6249
Revenue (TTM): $5.11 M
Dividend Yield: N/A%
ROE: -10.26%
Latest News
-
10x Genomics, Inc. (TXG) Q4 2025 Earnings Call Transcript
Sat, Feb 14, 2026 12:27 AM
-
Expert Outlook: 10x Genomics Through The Eyes Of 10 Analysts
Fri, Feb 13, 2026 5:00 PM
-
10x Genomics shares are trading higher after multiple analyst firms raised their respective price targets on the stock.
Fri, Feb 13, 2026 1:09 PM
-
Stifel Maintains Buy on 10x Genomics, Raises Price Target to $20
Fri, Feb 13, 2026 12:30 PM
-
TD Cowen Maintains Hold on 10x Genomics, Raises Price Target to $19
Fri, Feb 13, 2026 11:30 AM
-
10X Genomics (NASDAQ:TXG) Posts Q4 Earnings Beat Amid Cautious 2026 Outlook
Thu, Feb 12, 2026 11:23 PM
-
10x Genomics shares are trading lower. The company reported Q4 financial results.
Thu, Feb 12, 2026 5:32 PM
-
10x Genomics Sees FY2026 Sales $600.000M-$625.000M vs $611.577M Est
Thu, Feb 12, 2026 5:14 PM
-
10x Genomics Earnings Report: Q4 Overview
Thu, Feb 12, 2026 5:10 PM
-
10x Genomics Q4 EPS $(0.13) Beats $(0.20) Estimate, Sales $166.030M Beat $159.274M Estimate
Thu, Feb 12, 2026 5:09 PM
Key Financials
Financial data not available
